Drug companies interested in ME/CFS? A race to produce the first drug for ME/CFS? A race? Those almost sound like fantasies but that’s the message Jarred Younger brought in his recent video talk. The bottom line, he said, is that over the last three months he’s...
Jarred Younger was lured away from Stanford by a University that wanted to get a lead in an emerging field. By definition emerging fields are not quite there yet…they’re emerging. Picking a winner in the medical field sweepstakes may be a bit like backing...
(This blog is taken from three sources. A radio interview with Jarred Younger, information on the University of Alabama at Birmingham website and an interview I did with him. Thanks to Jarred for his time.) Unlike others, Younger was never phased by the lack of...
“the present findings offer clinical implications that may serve to guide future studies of the pathophysiology and management of a variety of persistent pain conditions.” Loggia et. al. Chronic pain was thought for many years to be mostly a neuronal problem. Over or...
Into the Big Leagues Low dose naltrexone (LDN) is able to do for some people with intractable pain what opioids and other drugs can’t do – reduce the pain. Those drugs have something LDN doesn’t, however, – FDA approval. You can’t prove that LDN works,...
Maija Haavisto is a Finish writer and Chronic Fatigue Syndrome patient who wrote the massive ME/CFS and FM compendium “Reviving the Broken Marionette: Treatments for CFS/ME and Fibromyalgia”. Maija’s health improved greatly with low dose...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.